Connective tissue diseases may pose additional risk from COVID-19

In hospitalised patients, connective tissue diseases might contribute to worse COVID-19 infection INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours. The goal […]

Read More…

Cytokine storm is a treatable complication of COVID-19

Use of an immunosuppressive strategy can improve recovery and lower death rates in COVID-19-associated CSS. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their […]

Read More…

Overlap in symptoms of rheumatic flare and COVID-19 may delay diagnosis

People with rheumatic diseases are more likely to suffer from severe symptoms of COVID-19. INTRODUCTION COVID-19 is the disease caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours […]

Read More…

No additional risk from COVID-19 for people with rheumatic diseases taking biologics and JAK inhibitors

There is no need for withdrawal of DMARDs during the COVID-19 pandemic. Introduction COVID-19 is caused by a new type of coronavirus called severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). It was declared a pandemic by the World Health Organization on 11 March 2020. COVID-19 has forced people to change their behaviours to try to limit […]

Read More…